Supriya Lifescience Limited Asset Resilience Ratio

Latest as of September 2025: 0.58%

Supriya Lifescience Limited asset resilience ratio. Supriya Lifescience Limited (SUPRIYA) has an Asset Resilience Ratio of 0.58% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SUPRIYA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs69.80 Million
≈ $754.86K USD Cash + Short-term Investments

Total Assets

Rs12.03 Billion
≈ $130.10 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Supriya Lifescience Limited (2018–2025)

Asset resilience ratio of Supriya Lifescience Limited from 2018 to 2025. This chart shows how Supriya Lifescience Limited's Asset Resilience Ratio has changed over time. Read Supriya Lifescience Limited debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Supriya Lifescience Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SUPRIYA asset base.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs69.80 Million 0.58%
Total Liquid Assets Rs69.80 Million 0.58%

Asset Resilience Insights

  • Limited Liquidity: Supriya Lifescience Limited maintains only 0.58% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Supriya Lifescience Limited Industry Peers by Asset Resilience Ratio

Compare Supriya Lifescience Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Samsung Biologics Co Ltd
KO:207940
Biotechnology 15.21%
Verona Pharma plc
F:I9SA
Biotechnology 0.00%
Asymchem Laboratories Tian Jin Co Ltd
SHE:002821
Biotechnology 5.07%
Immunovant Inc
NASDAQ:IMVT
Biotechnology 98.50%
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578
Biotechnology 21.11%
Tubize-Fin
BR:TUB
Biotechnology 2.50%
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
Biotechnology 2.03%
Amicus Therapeutics Inc
NASDAQ:FOLD
Biotechnology 8.37%

Supriya Lifescience Limited Asset Resilience Ratio by Year (2018–2025)

Supriya Lifescience Limited asset resilience ratio by year from 2018 to 2025. The table below shows the annual Asset Resilience Ratio data for Supriya Lifescience Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 5.44% Rs604.66 Million
≈ $6.54 Million
Rs11.12 Billion
≈ $120.29 Million
+1.64pp
2024-03-31 3.80% Rs350.04 Million
≈ $3.79 Million
Rs9.21 Billion
≈ $99.63 Million
-5.98pp
2023-03-31 9.78% Rs802.11 Million
≈ $8.67 Million
Rs8.20 Billion
≈ $88.71 Million
+1.73pp
2022-03-31 8.05% Rs591.55 Million
≈ $6.40 Million
Rs7.35 Billion
≈ $79.46 Million
-1.58pp
2021-03-31 9.63% Rs429.28 Million
≈ $4.64 Million
Rs4.46 Billion
≈ $48.21 Million
-12.12pp
2020-03-31 21.75% Rs731.62 Million
≈ $7.91 Million
Rs3.36 Billion
≈ $36.38 Million
+17.53pp
2019-03-31 4.21% Rs106.66 Million
≈ $1.15 Million
Rs2.53 Billion
≈ $27.37 Million
+1.82pp
2018-03-31 2.39% Rs58.74 Million
≈ $635.25K
Rs2.45 Billion
≈ $26.54 Million
--
pp = percentage points

About Supriya Lifescience Limited

NSE:SUPRIYA India Biotechnology
Market Cap
$605.62 Million
Rs56.00 Billion INR
Market Cap Rank
#10930 Global
#552 in India
Share Price
Rs695.80
Change (1 day)
-19.99%
52-Week Range
Rs553.35 - Rs1052.50
All Time High
Rs1052.50
About

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti"hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary… Read more